Search
for
Sort by
Research 721–750 of 1000+
- Clinical and preclinical approach in AGA treatment: a review of current and new therapies in the regenerative field
- Autophagy Dysfunction: The Kernel of Hair Loss?
- The JAK/STAT signaling pathway: from bench to clinic
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Vitamin D: More Than a “Bone-a-Fide” Hormone
- The Rotterdam Study: 2012 objectives and design update
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Progress in Gelatin as Biomaterial for Tissue Engineering
- Pathophysiological mechanisms implicated in postpartum depression
- Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis
- Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies
- Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis
- Minoxidil and its use in hair disorders: a review
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- Development and homeostasis of the sebaceous gland
- Treatment of Obstructive Sleep Apnea Improves Cardiometabolic Function in Young Obese Women with Polycystic Ovary Syndrome
- The Many Faces of Calcineurin Inhibitor Toxicity—What the FK?
- WNT10A mutation causes ectodermal dysplasia by impairing progenitor cell proliferation and KLF4-mediated differentiation
- Mesenchymal stem cell therapy for liver disease: full of chances and challenges
- Effects of Melatonin Supplementation on Hormonal, Inflammatory, Genetic, and Oxidative Stress Parameters in Women With Polycystic Ovary Syndrome
- Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis
- Alopecia: evaluation and treatment
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
- Male sex hormones, aging, and inflammation
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- Pre-receptor regulation of the androgen receptor
- Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases
- Proliferative and Non-Proliferative Lesions of the Rat and Mouse Integument